Thursday September 13 |
| | | What’s new in research on bicuspid aortopathy? | |||
| Simon Body, Bart Loeys | ||||
| 08.30 |
|
| The complex genetic architecture of bicuspid aortic valve related aortopathy, Bart Loeys |
| 08.38 |
|
| Protein-altering and regulatory genetic variants near GATA4 implicated in BAV, Simon Body |
| 08.46 |
|
| New insights in the genetics of aortopathy and BAV in Turner syndrome, Aline Verstraeten |
| 08.54 |
|
| Circulating microRNAs in bicuspid aortopathy, Evaldas Girdauskas |
| 09.02 | TGF-b/ENG ratio in bicuspid aortopathy, Alessandro Della Corte  | |||
| 09.10 | Discussion | |||
| | | What’s new in management of bicuspid aortopathy? | |||
| Alessandro Della Corte, Hector Michelena | ||||
| 09.35 | Fluid dynamics simulations to understand BAV aortopathy mechanisms and risks, Luca Koechlin | |||
| 09.43 | Searching for early biomechanically-driven indexes of aortic remodeling: where are we at? Emiliano Votta | |||
| 09.51 | Advanced imaging biomarkers in bicuspid aortic valve disease surveillance, Malenka Bissell | |||
| 09.59 | Gender-related differences in bicuspid aortopathy history and outcomes, Hector Michelena | |||
| 10.07 | How does the current knowledge on BAV aortopathy impact valve repair? Alessandro Della Corte | |||
| 10.15 | Phenotype-guided surgical treatment of bicuspid aortopathy, Ruggero De Paulis | |||
| 10.23 | Discussion | |||
| 10.50 | Coffee break | |||
| Ask to expert I (Nagelmackers room – Level 2) | ||||
Place of the laparoscopy in the management of the Type 2 endoleaks, Eric Allaire, Franco Grego, | ||||
| Short communication: unusual complication of IMA embolization for type 2 endoleaks, Arnaud Kerzmann | ||||
| | | TAVI | |||
| Patrizio Lancellotti, Thomas Modine | ||||
| 11.20 | Overview on ongoing randomized clinical trials in TAVI, Patrizio Lancellotti | |||
| 11.28 | Is TAVR already arguable in low and moderate risk patients? Thomas Modine | |||
| 11.36 | Aortic regurgitation after TAVI - Can we do better? Joëlle Kefer | |||
| 11.44 | TAVI endocarditis, Bernard Iung | |||
| 11.52 | Experience from CHU Liège, Belgium, Christophe Martinez, Mark Radermecker | |||
| 12.00 | Perceval (suturless valve) indications at CHU Liège; a booster of the mini invasive aortic valve replacement program, Marc Radermecker | |||
| Keynote lecture | ||||
| 12.08 | Aortic valve reconstruction using the Ozaki technique, when and in whom? Cesare Quarto | |||
| 12.18 | Discussion | |||
| 12.30 | Lunch Break | |||
| | | Keynote lecture | |||
| Rodolphe Durieux | ||||
| 13.30 | Open reoperations for complications of endovascular aortic procedures: top of the iceberg? Nicholas Kouchoukos | |||
| | | Experts panels What is the aortic size threshold for TAA intervention? | |||
| Natzi Sakalihasan | ||||
Panelists: John Elefteriades, Nicholas Kouchoukos, Patrizio Lancellotti, Dianna Milewicz, Christoph Nienaber | ||||
| 13.45 | Should the criterion for surgical intervention for thoracic aortic aneurysm be moved “leftward” (earlier)? John Elefteriades | |||
| 13.55 | Lesson learned from local experiences in Liège with type A dissection, Natzi Sakalihasan | |||
| 14.00 | Discussion | |||
| | | The revised ascending aorta and aortic arch | |||
| Jean-Olivier Defraigne, John Elefteriades, Nicholas Kouchoukos | ||||
| 14.15 | Genetic basis of thoracic aortic disease and impact of altered gene on patient management, Dianna Milewicz | |||
| 14.23 | The z-score-misleading clinical science? John Elefteriades | |||
| 14.31 | Arch variants, Tilo Kölbel | |||
| 14.39 | Surgery of the aortic arch nowadays, Nicholas Kouchoukos | |||
| 14.47 | Arch hybrid procedures are effective and durable for arch aneurysms, Colin Bicknell | |||
| 14.55 | Endo-treatment of arch and ascending aorta, Tilo Kölbel | |||
| 15.03 | Discussion | |||
| 15.30 | Coffee break | |||
| | | Distal aortic dissection | |||
| Bijan Modarai, Christoph Nienaber | ||||
| 16.00 | The conundrum about complicated and uncomplicated type B dissection - new concepts! Christoph Nienaber | |||
| 16.08 | When is a dissection to be called chronic and why? Firas Mussa | |||
| 16.16 | What is the role of tissue inflammation in dissection and how do we diagnose it? Natzi Sakalihasan | |||
| 16.24 | How can imaging tell us about the plasticity of a dissection? Biomechanical modelling and PET/CT in type B aortic dissection: development of the Perth-Liege risk score for TBAD, Barry Doyle | |||
| 16.32 | Temporal and morphological patterns predict outcome of endovascular repair in acute complicated type B aortic dissection, Rebecka Hultgren | |||
| 16.40 | Critical aortic dissections: benefit of surgical creativity out of any guidelines, Parla Astarci | |||
| 16.48 | Discussion | |||
| | | Distal aortic dissection | |||
| Dianna Milewicz, Toru Suzuki | ||||
| 17.10 | The role of biomarkers in the setting of acute aortic syndrome? Toru Suzuki | |||
| 17.18 | The integration of genetic testing in the work-up of a patient with aortic dissection, Bulat Ziganshin | |||
| 17.26 | How to manage acute aortic dissection in pregnancy? John Elefteriades | |||
| 17.34 | Discussion | |||
| | | Proximal aortic dissection | |||
| Colin Bicknell, John Elefteriades | ||||
| 18.00 | The role of false lumen intervention to promote remodeling via induced thrombosis, Christoph Nienaber | |||
| 18.08 | How much is arch reconstruction needed in type A aortic dissection? Ulrich Rosendahl | |||
| 18.16 | Inching toward an endovascular solution for proximal dissection - will an Endo-Bentall see the light of day? Christoph Nienaber | |||
| 18.24 | Open surgery for aortic dissections, Nimesh Desai | |||
| 18.32 | Abdominal aortic open fenestration and other open surgical tricks: usefulness in type B dissections, Fabien Koskas | |||
| 18.40 | Optimised management of type A aortic dissection with visceral malperfusion - concept to reconsider, Mathias Thielmann | |||
| 18.48 | Short communication: the images behind intramural haematoma, Andreas Mitsis | |||
| 18.53 | Discussion | |||
| 19.15 | End of the sessions | |||
| 20.00 | Official dinner |